ES2141830T3 - Derivado de diester fosfonico. - Google Patents

Derivado de diester fosfonico.

Info

Publication number
ES2141830T3
ES2141830T3 ES94923088T ES94923088T ES2141830T3 ES 2141830 T3 ES2141830 T3 ES 2141830T3 ES 94923088 T ES94923088 T ES 94923088T ES 94923088 T ES94923088 T ES 94923088T ES 2141830 T3 ES2141830 T3 ES 2141830T3
Authority
ES
Spain
Prior art keywords
halogeno
represents hydrogen
lower alkyl
phosphonic
diester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94923088T
Other languages
English (en)
Spanish (es)
Inventor
Kazuyoshi Miyata
Yasuhisa Virasezon Kurogi
Yoshihiko Tsuda
Kazuhiko Tsutsumi
Takeshi Iwamoto
Chieko Naba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2141830T3 publication Critical patent/ES2141830T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES94923088T 1993-08-20 1994-08-08 Derivado de diester fosfonico. Expired - Lifetime ES2141830T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20625993 1993-08-20

Publications (1)

Publication Number Publication Date
ES2141830T3 true ES2141830T3 (es) 2000-04-01

Family

ID=16520375

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94923088T Expired - Lifetime ES2141830T3 (es) 1993-08-20 1994-08-08 Derivado de diester fosfonico.

Country Status (12)

Country Link
US (1) US5527786A (enExample)
EP (1) EP0666265B1 (enExample)
JP (1) JP3074332B2 (enExample)
KR (1) KR100305959B1 (enExample)
CN (1) CN1043897C (enExample)
AT (1) ATE189224T1 (enExample)
AU (1) AU678276B2 (enExample)
CA (1) CA2147375C (enExample)
DE (1) DE69422793T2 (enExample)
ES (1) ES2141830T3 (enExample)
TW (1) TW268008B (enExample)
WO (1) WO1995006051A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3533542B2 (ja) * 1994-03-08 2004-05-31 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
WO2010129138A2 (en) * 2009-04-27 2010-11-11 Limerick Biopharma Phosphorylated and phosphonated pyrone analogs for therapeutic treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH471113A (de) * 1965-01-29 1969-04-15 Merck Ag E Verfahren zur Herstellung von wasserlöslichen Flavanoidderivaten
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
US4434162A (en) * 1981-02-17 1984-02-28 Kanebo, Ltd. Phosphonic acid ester, pharmaceutical compositions containing the same and method of using the same
JPS5851958B2 (ja) * 1982-01-30 1983-11-19 カネボウ株式会社 新規１−（ベンゾチアゾ−ル−２−イル）−４−ジエトキシ−又はジイソプロポキシ−ホスフイニルベンゼン
US4870199A (en) * 1986-04-30 1989-09-26 Sandoz Pharm. Corp. Processes for the synthesis of diprotected R[R*,S*]-3,5-dihydroxy-6-oxohexanoate esters
JPH0651625B2 (ja) * 1986-12-29 1994-07-06 株式会社大塚製薬工場 高脂質血症治療剤
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds
AU606808B2 (en) * 1988-06-29 1991-02-14 Otsuka Pharmaceutical Factory, Inc. Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
JP2584336B2 (ja) * 1989-05-30 1997-02-26 株式会社大塚製薬工場 カルボン酸アミド誘導体
JP2549950B2 (ja) * 1991-01-24 1996-10-30 株式会社大塚製薬工場 イミダゾ［１，２−ａ］ピリジン誘導体、その製造方法及びその中間体としてのα−ハロケトン誘導体
JP2696150B2 (ja) * 1991-02-05 1998-01-14 株式会社大塚製薬工場 キノリン誘導体
JP2869608B2 (ja) * 1992-04-28 1999-03-10 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体

Also Published As

Publication number Publication date
AU7276394A (en) 1995-03-21
TW268008B (enExample) 1996-01-11
JP3074332B2 (ja) 2000-08-07
CA2147375C (en) 2003-02-11
AU678276B2 (en) 1997-05-22
ATE189224T1 (de) 2000-02-15
EP0666265B1 (en) 2000-01-26
KR100305959B1 (ko) 2001-12-28
CN1043897C (zh) 1999-06-30
DE69422793D1 (de) 2000-03-02
CA2147375A1 (en) 1995-03-02
KR950704335A (ko) 1995-11-17
CN1114835A (zh) 1996-01-10
DE69422793T2 (de) 2000-06-21
EP0666265A1 (en) 1995-08-09
WO1995006051A1 (en) 1995-03-02
US5527786A (en) 1996-06-18
EP0666265A4 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
ID24166A (id) Turunan piridazin baru dan obat-obatan yang mengandung hal yang sama sebagai ramuan efektif
NO20001816L (no) Substituerte, kondenserte heterosykliske forbindelser
DE69426157D1 (de) 1,4-di(phenylalkyl)piperazinderivate
CY1109256T1 (el) Κυανο-υποκατεστημενα παραγωγα ολεανολικου οξεος ως αναστολεις παραγωγης νο
DK0778277T3 (da) Substituerede heterocycliske derivater som CRF antagonister
TW260664B (enExample)
AU9281198A (en) Benzofuran derivatives
FI851931A0 (fi) Nya -karbolin-3-oxadiazolylderivat, foerfarande foer deras framstaellning samt deras anvaendning.
FI953710A0 (fi) Uusia pyrrolokarbatsoleja
ATE89003T1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
ES2141830T3 (es) Derivado de diester fosfonico.
DE69007572D1 (de) Chalkonderivate.
EP1103548A4 (en) TRIAZOLONE DERIVATIVES, THEIR USE AND INTERMEDIATE CONNECTION THEREFOR
DK0821955T3 (da) Anvendelse af 3-(4-heoxyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) til behandling af bipolar lidelse
DE69012451D1 (de) Cyanoguanidin-Derivate.
MX9706627A (es) Derivado de tiazolidinona opticamente activo.
GB2323369A (en) Heteropolyfunctional reactive disaro dyes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 666265

Country of ref document: ES